Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folate-targeted microbubbles are **microbubble-based nanoparticles modified by conjugation with folic acid or folate derivatives** to enable active targeting of cells that overexpress the **folate receptor**, which is commonly upregulated on various cancer cells[7][1][2][5]. These microbubbles serve as carriers for imaging agents or therapeutics (such as drugs or genes) and can be loaded with agents like doxorubicin, superparamagnetic iron oxide nanoparticles, or DNA[1][2]. Mechanistically, the folate conjugation enhances cell-specific uptake via high-affinity binding to folate receptor proteins, facilitating receptor-mediated endocytosis into target cells[7][1][5]. When combined with ultrasound, these microbubbles can be disrupted (sonoporation) at targeted tissues, triggering localized drug or gene release and enhancing intracellular delivery[1][2][3]. Their primary indications—and main area of research—include **image-guided cancer therapy** (especially for breast cancer and glioblastoma) and local gene delivery in brain tumor applications[1][2][5]. Folate-targeted microbubbles are experimental agents in ultrasound-guided molecular imaging, cancer diagnosis, and therapy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on folate-targeted microbubbles.